Traumatic Brain Injuries Assessment and Management Devices Market Report 2025

This Traumatic Brain Injuries Assessment and Management Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The traumatic brain injuries assessment and management devices market size has grown strongly in recent years. It will grow from $3.49 billion in 2024 to $3.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to historical developments in imaging modalities, military research and funding, clinical research and evidence-based practices, regulatory framework development, and increased awareness about the importance of early detection and appropriate management.

The traumatic brain injuries assessment and management devices market size is expected to see strong growth in the next few years. It will grow to $5.32 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the rising incidence of traumatic brain injuries, the aging population is prone to falls and age-related brain injuries, heightened awareness of the long-term consequences of concussions, and government-supported research initiatives. Major trends in the forecast period include the integration of artificial intelligence (AI), wearable monitoring devices, expansion of telemedicine platforms and remote consultation services, advancements in non-invasive brain stimulation techniques, and the expansion of virtual reality (VR).

The rising number of road traffic crashes is expected to drive the growth of the traumatic brain injuries (TBI) assessment and management devices market. Road traffic crashes involve collisions between vehicles on public roads, leading to property damage, injuries, or fatalities. The increase in these crashes is often attributed to factors such as higher vehicle numbers, distracted driving, speeding, and inadequate infrastructure. TBI assessment and management devices play a crucial role in treating victims of road traffic accidents by allowing for the timely evaluation and monitoring of brain function, helping to guide appropriate medical interventions. For example, in August 2022, the National Highway Traffic Safety Administration, a US-based government agency, reported that the fatality rate for the first quarter of 2022 increased to 1.27 fatalities per 100 million vehicle miles traveled, compared to 1.25 fatalities per 100 million vehicle miles in the first quarter of 2021. Additionally, in June 2022, the World Health Organization, a Switzerland-based intergovernmental organization, reported that road traffic accidents claimed nearly 1.3 million lives annually. As a result, the growing number of road traffic crashes is fueling the expansion of the TBI assessment and management devices market.

Prominent companies in the traumatic brain injuries assessment and management devices market are directing their efforts towards the development of innovative products, such as diagnostic handheld devices, aimed at enhancing portability and accessibility for more effective TBI detection and management. Diagnostic handheld devices typically denote portable instruments equipped with sensors or technologies utilized for swift assessment and identification of potential brain injuries at the point of care outside conventional clinical settings, providing convenience and immediate results. For example, in November 2023, the University of Birmingham, a US-based research university and academic medical center, introduced a groundbreaking diagnostic device designed to detect traumatic brain injury (TBI) by employing a safe laser beam directed into the eye. This system integrates a class 1 CE-marked, eye-safe laser with a Raman spectroscopy setup, utilizing light to reveal the biochemical and structural characteristics of molecules through the analysis of their light scattering, thereby detecting the presence and quantities of established biomarkers associated with brain injury.

In March 2022, NeuroCatch Inc., a neuro-health technology firm situated in Canada, entered into a partnership with BioFlex Inc., with the intention of amalgamating their inventive technologies. This joint effort seeks to equip healthcare providers with cutting-edge tools and methodologies to bolster brain health. Their primary objective is to propel research into the advantages of photobiomodulation therapy (PBMT) concerning brain health, particularly in the domain of traumatic brain injury. Meditech International Inc., a US-based company specializing in photobiomodulation therapy intended to enhance brain function and facilitate recovery.

Major companies operating in the traumatic brain injuries assessment and management devices market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Canon Medical Systems Corporation (CMSC), Masimo Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Neurosoft SA, Cadwell Industries Inc., NeuroPace Inc., Compumedics Limited, Emotiv Inc., Micromed LLC, Electrical Geodesics Inc., ANT Neuro, Neuroelectrics Corporation, BrainScope Company Inc., Hyperfine Research Inc., Advanced Brain Monitoring Inc., Moberg Research Inc., Mitsar Co. Ltd., ELMIKO Medical Equipment.

North America was the largest region in the traumatic brain injuries assessment and management devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the traumatic brain injuries assessment and management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the traumatic brain injuries assessment and management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Traumatic brain injury (TBI) assessment and management devices encompass medical tools and technology designed for diagnosing, assessing, monitoring, and treating individuals affected by TBI. Healthcare professionals utilize these devices to enhance the precision of TBI diagnosis, ensure ongoing patient monitoring, evaluate cognitive and functional impairments, and implement suitable treatment and rehabilitation strategies, thus enhancing patient outcomes.

The primary devices for assessing and managing traumatic brain injury are imaging devices and monitoring devices. Imaging devices are medical instruments employed to visualize the brain and evaluate traumatic brain injuries (TBI). They encompass diverse technologies, including intracranial pressure (ICP) monitoring and measuring the partial pressure of oxygen in brain tissue, utilized by various end-users such as hospitals, diagnostic centers, and others.

The traumatic brain injuries assessment and management devices market research report is one of a series of new reports that provides traumatic brain injuries assessment and management devices market statistics, including traumatic brain injuries assessment and management devices industry global market size, regional shares, competitors with a traumatic brain injuries assessment and management devices market share, detailed traumatic brain injuries assessment and management devices market segments, market trends and opportunities, and any further data you may need to thrive in the traumatic brain injuries assessment and management devices industry. This traumatic brain injuries assessment and management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The traumatic brain injuries assessment and management devices market consists of sales of intracranial pressure monitoring devices (ICP Monitors), EEG (electroencephalogram), cerebral oximeters, Glasgow coma scale (GCS), and neurological examination tools (reflex hammers, tuning forks). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.